← FDA DRUG APPROVALS

FDA ANDA · ANDA212238

TRIENTINE HYDROCHLORIDE

Sponsor: RISING

APPLICATION
ANDA212238
TYPE
ANDA
ORIGINAL APPROVAL
2020-02-20
LATEST ACTION
2023-09-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

TRIENTINE HYDROCHLORIDEPrescription
TRIENTINE HYDROCHLORIDE 500MG · CAPSULE · ORAL
TRIENTINE HYDROCHLORIDEPrescription
TRIENTINE HYDROCHLORIDE 250MG · CAPSULE · ORAL

Approval history

2023-09-22Manufacturing (CMC) · Supplement 2 · unknownAP
2021-03-30Manufacturing (CMC) · Supplement 1 · unknownAP
2020-02-20UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →